Timothy Wilkin received his undergraduate degree in Mathematics at the University of Texas at Austin and attended medical school at Ohio State University. He went on to complete his residency in Internal Medicine at the University of Chicago Hospitals. He received fellowship training in Infectious Diseases at Columbia University and was supported by an Individual National Research Service Award from the National Institutes of Health. While at Columbia, he completed a Master's of Public Health with a concentration in Patient-Oriented Research. He was invited to join the faculty of Weill-Cornell Medical. He received a K23 Grant (Mentored Patient-Oriented Research Career Development Award) from the National Institutes of Health. He has chaired or co-chaired 10 multi-site clinical in the AIDS Clinical Trials Group, AIDS Malignancy Consortium and HIV Prevention Trials Network. His current work focuses on HPV vaccination and the treatment of HPV-associated dysplasia in HIV-infected populations.
At the completion of this educational session, learners will:
- Be aware of new data on HIV treatment strategies, including treatment initiation, and choosing regimens after treatment failure.
- Know about agents in development for HIV treatment.
- Learn about new data on HIV prevention, including outcomes from recent PrEP studies.
This CME activity was approved for AMA PRA Category 1 Credit™
on May 23, 2017 and will terminate May 22, 2020.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Wilkin (Presenter) has had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Research support from Gilead, BMS, and GSK/ViiV; Honorarium from GSK/ViiV. Dr. Wilkin submitted his slides in advance for adequate peer review and will support his presentation and clinical recommendations with the best available evidence from the medical literature.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Merck & Co, and ViiV Healthcare.
To obtain CME credit for this PRN program, please visit the PRN Courses Page
at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.